Showing results (171-180 of 229) with videos related to
Sort By:
Pageof 23
Nature Aging|February 3, 2026
Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretomeEstela González-Gualda, Marika A V Reinius, David Macias, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
DNA Methylation Profiles of Ovarian Clear Cell CarcinomaJulie M Cunningham, Stacey J Winham, Chen Wang, et al.EMBO Molecular Medicine|August 21, 2024
Novel immunotherapeutics against LGR5 to target multiple cancer typesHung-Chang Chen, Nico Mueller, Katherine Stott, et al.ESMO Open|September 21, 2018
Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine ProgrammeColin R Lindsay, Emily C Shaw, Fiona Blackhall, et al.European Journal of Human Genetics : EJHG|February 12, 2025
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancerEd M Dicks, Jonthan P Tyrer, Suzana Ezquina, et al.Nature Communications|October 26, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancerFilipe Correia Martins, Dominique-Laurent Couturier, Ines de Santiago, et al.The Lancet. Oncology|December 3, 2016
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trialElizabeth M Swisher, Kevin K Lin, Amit M Oza, et al.EJNMMI Research|April 17, 2025
Assessment of early response to neoadjuvant chemotherapy in multi-site high-grade serous ovarian cancer using hyperpolarized-<sup>13</sup>C MRILucian Beer, Vlad Bura, Stephan Ursprung, et al.Gynecologic Oncology|November 19, 2022
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgeryMinh Tung Phung, Penelope M Webb, Anna DeFazio, et al.Nature Genetics|June 23, 2025
Predicting resistance to chemotherapy using chromosomal instability signaturesJoe Sneath Thompson, Laura Madrid, Barbara Hernando, et al.Pageof 23